Pages that link to "Q37521082"

The following pages link to Targeting CD133 antigen in cancer (Q37521082):

Displaying 46 items.

• CD133 antigen expression in ovarian cancer (Q21093306) (← links)
• Post-translational regulation of CD133 by ATase1/ATase2-mediated lysine acetylation (Q24337923) (← links)
• Non-invasive in vivo imaging of tumor-associated CD133/prominin (Q27438105) (← links)
• CD133, Selectively Targeting the Root of Cancer (Q28066353) (← links)
• Aberrant expression of CD133 protein correlates with Ki-67 expression and is a prognostic marker in gastric adenocarcinoma (Q33582684) (← links)
• Genome and transcriptome profiles of CD133-positive colorectal cancer cells. (Q33855041) (← links)
• Epithelial to mesenchymal transition by TGFβ-1 induction increases stemness characteristics in primary non small cell lung cancer cell line (Q33955042) (← links)
• The importance of the stem cell marker prominin-1/CD133 in the uptake of transferrin and in iron metabolism in human colon cancer Caco-2 cells (Q34038381) (← links)
• The endoplasmic reticulum-based acetyltransferases, ATase1 and ATase2, associate with the oligosaccharyltransferase to acetylate correctly folded polypeptides (Q34509754) (← links)
• CD117⁺ cells in the circulation are predictive of advanced prostate cancer (Q35176469) (← links)
• Ovarian cancer stem cell markers: prognostic and therapeutic implications (Q35606242) (← links)
• Aberrant Expression of Cancer Stem Cells Marker Prominin-1 in Low-Grade Tubulolobular Breast Carcinoma: A Correlative Study between qRT-PCR, Flow-Cytometric and Immunohistochemistry Analysis [corrected]. (Q35866920) (← links)
• Pharmacogenetic profiling of CD133 is associated with response rate (RR) and progression-free survival (PFS) in patients with metastatic colorectal cancer (mCRC), treated with bevacizumab-based chemotherapy (Q35888438) (← links)
• Induction of cancerous stem cells during embryonic stem cell differentiation (Q36347664) (← links)
• Polarized cell migration induces cancer type-specific CD133/integrin/Src/Akt/GSK3β/β-catenin signaling required for maintenance of cancer stem cell properties. (Q36545955) (← links)
• Symptomatic cardiac metastases of breast cancer 27 years after mastectomy: a case report with literature review--pathophysiology of molecular mechanisms and metastatic pathways, clinical aspects, diagnostic procedures and treatment modalities (Q36581353) (← links)
• In vitro expansion of human glioblastoma cells at non-physiological oxygen tension irreversibly alters subsequent in vivo aggressiveness and AC133 expression (Q36645642) (← links)
• Regulation of CD133 by HDAC6 promotes β-catenin signaling to suppress cancer cell differentiation (Q36664232) (← links)
• Human osteosarcoma CD49f(-)CD133(+) cells: impaired in osteogenic fate while gain of tumorigenicity (Q37626756) (← links)
• Targeting tissue factor as a novel therapeutic oncotarget for eradication of cancer stem cells isolated from tumor cell lines, tumor xenografts and patients of breast, lung and ovarian cancer (Q37702117) (← links)
• CD133-targeted niche-dependent therapy in cancer: a multipronged approach (Q37734881) (← links)
• The challenges of integrating molecular imaging into the optimization of cancer therapy. (Q37871875) (← links)
• CD133+ cells as a therapeutic target for kidney diseases (Q37983119) (← links)
• A versatile lentiviral expression system to identify mammalian protein-protein interactions. (Q38020053) (← links)
• CD133 as a biomarker for putative cancer stem cells in solid tumours: limitations, problems and challenges (Q38035206) (← links)
• Stem cells and cancer stem-like cells in endocrine tissues (Q38084129) (← links)
• Cancer stem cell markers: what is their diagnostic value? (Q38089898) (← links)
• A bispecific EpCAM/CD133-targeted toxin is effective against carcinoma (Q38867217) (← links)
• Enhanced cell growth and tumorigenicity of rat glioma cells by stable expression of human CD133 through multiple molecular actions (Q39129183) (← links)
• CD133 protein N-glycosylation processing contributes to cell surface recognition of the primitive cell marker AC133 epitope (Q39243687) (← links)
• Growth kinetics of CD133-positive prostate cancer cells (Q39247506) (← links)
• Trending Speculations of Tumor-Initiating Cells in Squamous Cell Cancers of Head and Neck (Q39264794) (← links)
• RalA is overactivated in medulloblastoma (Q39449209) (← links)
• Arsenic oxide targets stem cell marker CD133/prominin-1 in gallbladder carcinoma (Q39501098) (← links)
• Cytoprotective effect of neuropeptides on cancer stem cells: vasoactive intestinal peptide-induced antiapoptotic signaling (Q41083994) (← links)
• Immunotherapeutic Concepts to Target Acute Myeloid Leukemia: Focusing on the Role of Monoclonal Antibodies, Hypomethylating Agents and the Leukemic Microenvironment (Q41573313) (← links)
• Tetraspecific scFv construct provides NK cell mediated ADCC and self-sustaining stimuli via insertion of IL-15 as a cross-linker (Q42221543) (← links)
• The clinicopathological parameters significance of CD133 and Nestin in epithelial ovarian cancer: a meta-analysis. (Q47821773) (← links)
• Differential survival of AML subpopulations in NOD/SCID mice (Q53288717) (← links)
• CD133-directed CAR T cells for advanced metastasis malignancies: A phase I trial. (Q55477963) (← links)
• Therapeutic Antibody-Like Immunoconjugates against Tissue Factor with the Potential to Treat Angiogenesis-Dependent as Well as Macrophage-Associated Human Diseases (Q60584701) (← links)
• Therapeutic Targeting Strategies of Cancer Stem Cells in Gastrointestinal Malignancies (Q64110601) (← links)
• PROM1 and PROM2 expression differentially modulates clinical prognosis of cancer: a multiomics analysis (Q92525857) (← links)
• TREX1 suppression imparts cancer-stem-cell-like characteristics to CD133- osteosarcoma cells through the activation of E2F4 signaling (Q92617776) (← links)
• Targeting Cancer Stem Cells by Genetically Engineered Chimeric Antigen Receptor T Cells (Q94545537) (← links)
• Clinical development of CAR T cell therapy in China: 2020 update (Q100395396) (← links)